% alzhub.org library filter
% Source: https://alzhub.org/research?author=Vellas+B&atag=randomized
% 15 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{egan2019-30970186,
  author  = {Egan, M. F. and Kost, J. and Voss, T. and Mukai, Y. and Aisen, P. S. and Cummings, J. L. and Tariot, P. N. and Vellas, B. and others},
  title   = {{Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2019},
  doi     = {10.1056/nejmoa1812840},
  pmid    = {30970186},
  url     = {https://doi.org/10.1056/nejmoa1812840}
}

@article{egan2018-29719179,
  author  = {Egan, M. F. and Kost, J. and Tariot, P. N. and Aisen, P. S. and Cummings, J. L. and Vellas, B. and Sur, C. and Mukai, Y. and others},
  title   = {{Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2018},
  doi     = {10.1056/nejmoa1706441},
  pmid    = {29719179},
  url     = {https://doi.org/10.1056/nejmoa1706441}
}

@article{honig2018-29365294,
  author  = {Honig, L. S. and Vellas, B. and Woodward, M. and Boada, M. and Bullock, R. and Borrie, M. and Hager, K. and Andreasen, N. and others},
  title   = {{Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2018},
  doi     = {10.1056/nejmoa1705971},
  pmid    = {29365294},
  url     = {https://doi.org/10.1056/nejmoa1705971}
}

@article{vandyck2023-22dd8fce,
  author  = {van Dyck, C. H. and Swanson, C. J. and Aisen, P. and Bateman, R. J. and Chen, C. and Gee, M. and Kanekiyo, M. and Li, D. and Reyderman, L. and Cohen, S. and Froelich, L. and Katayama, S. and Sabbagh, M. and Vellas, B. and Watson, D. and Dhadda, S. and Irizarry, M. and Kramer, L. D. and Iwatsubo, T.},
  title   = {{Lecanemab in Early Alzheimer's Disease}},
  journal = {New England Journal of Medicine},
  year    = {2023},
  pmid    = {36449413}
}

@article{feldman2001-11524468,
  author  = {Feldman, H. and Gauthier, S. and Hecker, J. and Vellas, B. and Subbiah, P. and Whalen, E. and {Donepezil MSAD Study Investigators Group}},
  title   = {{A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease}},
  journal = {Neurology},
  year    = {2001},
  doi     = {10.1212/wnl.57.4.613},
  pmid    = {11524468},
  url     = {https://doi.org/10.1212/wnl.57.4.613}
}

@article{rolland2019-31426362,
  author  = {Rolland, Y. and Barreto, P. S. and Maltais, M. and Guyonnet, S. and Cantet, C. and Andrieu, S. and Vellas, B.},
  title   = {{Effect of Long-Term Omega 3 Polyunsaturated Fatty Acid Supplementation with or without Multidomain Lifestyle Intervention on Muscle Strength in Older Adults: Secondary Analysis of the Multidomain Alzheimer Preventive Trial (MAPT)}},
  journal = {Nutrients},
  year    = {2019},
  doi     = {10.3390/nu11081931},
  pmid    = {31426362},
  url     = {https://doi.org/10.3390/nu11081931}
}

@article{giudici2020-33036701,
  author  = {Giudici, K. V. and de Souto Barreto, P. and Beard, J. and Cantet, C. and Araujo de Carvalho, I. and Rolland, Y. and Vellas, B. and {MAPT DSA group}},
  title   = {{Effect of long-term omega-3 supplementation and a lifestyle multidomain intervention on intrinsic capacity among community-dwelling older adults: Secondary analysis of a randomized, placebo-controlled trial (MAPT study)}},
  journal = {Maturitas},
  year    = {2020},
  doi     = {10.1016/j.maturitas.2020.06.012},
  pmid    = {33036701},
  url     = {https://doi.org/10.1016/j.maturitas.2020.06.012}
}

@article{feldman2004-15326236,
  author  = {Feldman, H. and Gauthier, S. and Hecker, J. and Vellas, B. and Hux, M. and Xu, Y. and Schwam, E. M. and Shah, S. and others},
  title   = {{Economic evaluation of donepezil in moderate to severe Alzheimer disease}},
  journal = {Neurology},
  year    = {2004},
  doi     = {10.1212/01.wnl.0000134663.79663.6e},
  pmid    = {15326236},
  url     = {https://doi.org/10.1212/01.wnl.0000134663.79663.6e}
}

@article{vellas2006-17101932,
  author  = {Vellas, B. and Andrieu, S. and Ousset, P. J. and Ouzid, M. and Mathiex-Fortunet, H. and {GuidAge Study Group}},
  title   = {{The GuidAge study: methodological issues. A 5-year double-blind randomized trial of the efficacy of EGb 761 for prevention of Alzheimer disease in patients over 70 with a memory complaint}},
  journal = {Neurology},
  year    = {2006},
  doi     = {10.1212/wnl.67.9_suppl_3.s6},
  pmid    = {17101932},
  url     = {https://doi.org/10.1212/wnl.67.9_suppl_3.s6}
}

@article{feldman2003-12757558,
  author  = {Feldman, H. and Gauthier, S. and Hecker, J. and Vellas, B. and Emir, B. and Mastey, V. and Subbiah, P. and {Donepezil MSAD Study Investigators Group}},
  title   = {{Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden}},
  journal = {Journal of the American Geriatrics Society},
  year    = {2003},
  doi     = {10.1046/j.1365-2389.2003.51260.x},
  pmid    = {12757558},
  url     = {https://doi.org/10.1046/j.1365-2389.2003.51260.x}
}

@article{delrieu2023-37872582,
  author  = {Delrieu, J. and Vellas, B. and Guyonnet, S. and Cantet, C. and Ovod, V. and Li, Y. and Bollinger, J. and Bateman, R. and others},
  title   = {{Cognitive impact of multidomain intervention and omega 3 according to blood Aβ42/40 ratio: a subgroup analysis from the randomized MAPT trial}},
  journal = {Alzheimer's research \& therapy},
  year    = {2023},
  doi     = {10.1186/s13195-023-01325-3},
  pmid    = {37872582},
  url     = {https://doi.org/10.1186/s13195-023-01325-3}
}

@article{chhetri2018-29405230,
  author  = {Chhetri, J. K. and de Souto Barreto, P. and Cantet, C. and Cesari, M. and Coley, N. and Andrieu, S. and Vellas, B.},
  title   = {{Trajectory of the MAPT-PACC-Preclinical Alzheimer Cognitive Composite in the Placebo Group of a Randomized Control Trial: Results from the MAPT Study: Lessons for Further Trials}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2018},
  doi     = {10.14283/jpad.2017.21},
  pmid    = {29405230},
  url     = {https://doi.org/10.14283/jpad.2017.21}
}

@article{maltais2019-30817982,
  author  = {Maltais, M. and de Souto Barreto, P. and Pothier, K. and Cantet, C. and Andrieu, S. and Rolland, Y. and Vellas, B. and {MAPT/DSA Study Group}},
  title   = {{Lifestyle multidomain intervention, omega-3 supplementation, or both for reducing the risk of developing clinically relevant depressive symptoms in older adults with memory complaints? Secondary analysis from the MAPT trial}},
  journal = {Experimental gerontology},
  year    = {2019},
  doi     = {10.1016/j.exger.2019.02.010},
  pmid    = {30817982},
  url     = {https://doi.org/10.1016/j.exger.2019.02.010}
}

@article{gilletteguyonnet2009-19328438,
  author  = {Gillette-Guyonnet, S. and Andrieu, S. and Dantoine, T. and Dartigues, J. F. and Touchon, J. and Vellas, B. and {MAPT Study Group}},
  title   = {{Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer's disease}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2009},
  doi     = {10.1016/j.jalz.2009.01.008},
  pmid    = {19328438},
  url     = {https://doi.org/10.1016/j.jalz.2009.01.008}
}

@article{soto2015-25226218,
  author  = {Soto, M. and Andrieu, S. and Nourhashemi, F. and Ousset, P. J. and Ballard, C. and Robert, P. and Vellas, B. and Lyketsos, C. G. and others},
  title   = {{Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design}},
  journal = {International psychogeriatrics},
  year    = {2015},
  doi     = {10.1017/s1041610214001720},
  pmid    = {25226218},
  url     = {https://doi.org/10.1017/s1041610214001720}
}